Trastuzumab Completed Phase 3 Trials for HER2/Neu Over-expressing Locally Advanced Breast Cancer / Metastatic Breast Cancer (MBC) Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT02144012A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer
NCT01007942Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer